LauraChristineCappelliMD

Rheumatology • Baltimore, MD

Assistant Professor of Medicine

Join to view full profile

Dr. Cappelli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cappelli's full profile

Already have an account?

Office
4940 Eastern Avenue
Bayview Medical Offices, Level 01 (G), Clinic 5
Baltimore, MD 21224
Phone+1 443-997-1552

Fax+1 410-550-1033

Summary

I am a rheumatologist in academic medicine. I see patients with inflammatory arthritis and perform clinical research. My main clinical and research interest is rheumatic immune-related adverse events from immune checkpoint inhibitor therapies used to treat cancer. I also perform clinical and translational research in rheumatoid arthritis.

Education & Training

Johns Hopkins UniversityFellowship, Rheumatology, 2013 - 2016
Johns Hopkins Bloomberg School of Public HealthMHS, 2014 - 2015
Johns Hopkins UniversityResidency, Internal Medicine, 2010 - 2013
Johns Hopkins University School of MedicineClass of 2010

Certifications & Licensure

FL State Medical License 2020 - Present
MD State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Publications & Presentations

PubMed

1 citations
Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures.
Chester J Kao, Soren Charmsaz, Stephanie L Alden, Madelena Brancati, Howard L Li
The Journal of Clinical Investigation. 2024-08-29
1 citations
Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis.
Rachel S Wallwork, Jonathan J Kotzin, Laura C Cappelli, Christopher Mecoli, Clifton O Bingham 3rd
Seminars in Arthritis and Rheumatism. 2024-08-01
4 citations
Baseline predictors of disease severity in immune checkpoint inhibitor-induced inflammatory arthritis.
Laura C Cappelli, Omer Kamal, Michelle Jones, Clifton O Bingham 3rd, Ami A Shah
Rheumatology. 2024-05-03

Press Mentions

Toxic Trade-OffsMarch 16th, 2023
Highlights from the ACR Review Course 2022December 6th, 2022
5 Tips for Getting the Most Out of Your Next Rheumatoid Arthritis AppointmentMarch 10th, 2021
Join now to see all